HOME >> MEDICINE >> NEWS
Annals of Internal Medicine tip sheet, September 16, 2003

1. Chinese Herbal Weight-Loss Products Caused Liver Damage in Japan
Two herbal weight-loss products manufactured in China and sold in Japan and on the Internet caused liver injury to 12 patients taking the product, according to a new study (Brief Communication, p. 488). One patient died and another needed a liver transplant; the remaining patients recovered after stopping the products, Chaso and Onshido. Both were advertised by their manufacturers as containing only botanicals, but were found to contain N-nitroso-fenfluramine, a relative of the drug fenfluramine that was taken off the market in the United States after it was linked to heart problems. The authors caution that consumers and health professionals should be aware that so-called herbal supplements for weight loss may be harmful.

2. Blood Pressure Pills Protect Against Hip Fracture but Protection Disappears
In a follow-up study of 7,891 people 55 or older, those who took thiazide diuretics for at least one year had a 50 percent lower risk for hip fracture than people who never took the diuretics (Article, p. 476). The protective effect of these inexpensive pills, commonly prescribed to lower blood pressure, disappeared within four months after the pills were discontinued.

3. Consensus Group Develops 18 Criteria for Clinical Guidelines
A group of physicians and others with experience in developing clinical guidelines have come up with an 18-point checklist to standardize reporting of medical guidelines (Academia and Clinic, p. 493). The great variation in documentation of many current guidelines can lead to misunderstandings by clinicians, patients and reporters about what some guidelines actually recommend, thus reducing chances that they'll be adopted into clinical practice and improve medical care. The Conference on Guideline Standardization asks that guideline developers describe how the evidence was collected or evaluated, mention fun
'"/>

Contact: Penelope Fuller
pfuller@acponline.org
215-351-2656
American College of Physicians
15-Sep-2003


Page: 1 2

Related medicine news :

1. March/April 2005 Annals of Family Medicine tip sheet
2. Annals of Internal Medicine tip sheet for March 15, 2005
3. Feb. 15, 2005, Annals of Internal Medicine tip sheet
4. Feb. 1, 2005, Annals of Internal Medicine tip sheet
5. January/February Annals of Family Medicine tip sheet
6. Tip sheet Annals of Internal Medicine, Jan. 18, 2005
7. Tip sheet Annals of Internal Medicine, Jan. 4, 2005
8. Annals of Internal Medicine, tip sheet, Dec. 21, 2004
9. Dec. 7 tip sheet Annals of Internal Medicine
10. November/December 2004 Annals of Family Medicine tip sheet
11. Annals of Internal Medicine, tip sheet, Nov. 16, 2004

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Annals Internal Medicine tip sheet September

(Date:5/24/2013)... The British Menopause Society and Women,s Health Concern have ... to provide clarity around the role of HRT, the ... the society,s flagship title, Menopause International , published ... HRT has changed from being branded the "elixir of ... be used in certain circumstances. Since the publication of ...
(Date:5/24/2013)... Today marks the launch of Destination ... , The redesigned and enhanced Itinerary Builder will ... on their computer or mobile device that they can ... allows users to fill in their date of arrival ... their choice of vacation packages, accommodations, restaurants, and things ...
(Date:5/24/2013)... Wixom, MI (PRWEB) May 24, 2013 ... recent Cute Baby Photo Contest. Lindsey Willis of Olathe, ... Cuties-brand diapers from DiaperBuys. Second prize was a ... Heather Tacher, North Las Vegas, Nev.; and third prize, ... Texas. , The contest was run through the company’s ...
(Date:5/24/2013)... 2013 Wednesday, 15th May 2013 | 10am ... to access webinar playback: http://bit.ly/10Rt0ZH , Ongoing regulatory ... markets. Across the globe and particularly in Europe, a number ... M&A activity . For dealmakers, understanding how the likes of ... Tax’ affects your corner of the market will give you ...
(Date:5/24/2013)... San Diego, CA (PRWEB) May 24, 2013 ... informing consumers today of the latest update involving ... Zithromax and Zmax SR (azithromycin) can allegedly ... Canadian Broadcasting Company reported on May 17, 2013* ... and Drug Administration in warning that Zithromax can ...
Breaking Medicine News(10 mins):Health News:Create and Win the Perfect Halifax Getaway with the All-New Itinerary Builder 2Health News:DiaperBuys.com Announces Photo Contest Winners 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 2Health News:Register to Access Webinar Playback - The Impact of Financial Regulation on M&A in 2013 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 2Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 3Health News:2013 Alleged Zithromax Arrhythmia and Sudden Death Cases Update: Canadian Health Officials Issue Warning 4
(Date:5/24/2013)... YORK , May 24, 2013 In accordance ... Rules and Rule 14e-1 of the United States Exchange Act, ... its original offer for Elan Corporation (NYSE: ELN). ... Limited ("Royalty Pharma") made an offer for the entire of ... Corporation, plc ("Elan") (the "Original Offer").  On ...
(Date:5/23/2013)... , May 23, 2013  Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: ... been named the 2013 Life Science Firm of the Year ... (TCM).  Vanda was honored at the TCM,s 25 th ... , Maryland.  The Tech Awards Celebration recognizes the leaders and ... Maryland and the surrounding regions. ...
(Date:5/23/2013)... , May 23, 2013 Nephros, Inc. ... stage medical device company that develops and sells high ... of its rights offering.  In addition, the concurrent temporary ... warrants expired on May 17, 2013. Nephros ... million from the rights offering.   A portion of the ...
Breaking Medicine Technology:Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 2Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 3Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 4Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 5Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 6Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 7Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 8Royalty Pharma Discloses Acceptance Levels of Original Offer for Elan Pursuant to Irish and United States Regulatory Requirements 9Vanda Pharmaceuticals Named the 2013 Life Science Firm of the Year by the Tech Council of Maryland 2Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
Cached News: